These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31804596)

  • 1. Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice.
    Binyamin O; Nitzan K; Frid K; Ungar Y; Rosenmann H; Gabizon R
    Sci Rep; 2019 Dec; 9(1):18437. PubMed ID: 31804596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression.
    Saito T; Matsuba Y; Yamazaki N; Hashimoto S; Saido TC
    J Neurosci; 2016 Sep; 36(38):9933-6. PubMed ID: 27656030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer's disease.
    Agwa MM; Abdelmonsif DA; Khattab SN; Sabra S
    Int J Biol Macromol; 2020 Nov; 162():246-261. PubMed ID: 32531361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
    Devi L; Ohno M
    Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
    Hsiao YH; Kuo JR; Chen SH; Gean PW
    Neurobiol Dis; 2012 Mar; 45(3):1111-20. PubMed ID: 22227002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-PSO Administration Attenuates Cognitive and Neuronal Deficits Resulting from Traumatic Brain Injury.
    Qubty D; Frid K; Har-Even M; Rubovitch V; Gabizon R; Pick CG
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
    Ye CY; Lei Y; Tang XC; Zhang HY
    Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continues administration of Nano-PSO significantly increased survival of genetic CJD mice.
    Binyamin O; Keller G; Frid K; Larush L; Magdassi S; Gabizon R
    Neurobiol Dis; 2017 Dec; 108():140-147. PubMed ID: 28847567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.
    Devi L; Tang J; Ohno M
    Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease.
    Liang B; Duan BY; Zhou XP; Gong JX; Luo ZG
    J Biol Chem; 2010 Sep; 285(36):27737-44. PubMed ID: 20595388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
    Devi L; Ohno M
    Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of conjugated linoleic acid, μ-calpain inhibitor, on pathogenesis of Alzheimer's disease.
    Lee E; Eom JE; Kim HL; Baek KH; Jun KY; Kim HJ; Lee M; Mook-Jung I; Kwon Y
    Biochim Biophys Acta; 2013 Apr; 1831(4):709-18. PubMed ID: 23246577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
    Zhu H; Xue X; Wang E; Wallack M; Na H; Hooker JM; Kowall N; Tao Q; Stein TD; Wolozin B; Qiu WQ
    Neuropharmacology; 2017 Jun; 119():170-181. PubMed ID: 28363773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.
    Fà M; Zhang H; Staniszewski A; Saeed F; Shen LW; Schiefer IT; Siklos MI; Tapadar S; Litosh VA; Libien J; Petukhov PA; Teich AF; Thatcher GR; Arancio O
    J Alzheimers Dis; 2016; 49(3):707-21. PubMed ID: 26484927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD.
    Mizrahi M; Friedman-Levi Y; Larush L; Frid K; Binyamin O; Dori D; Fainstein N; Ovadia H; Ben-Hur T; Magdassi S; Gabizon R
    Nanomedicine; 2014 Aug; 10(6):1353-63. PubMed ID: 24704590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.